Imiquimod is FDA approved as a topical cream for the treatment of superficial basal cell carcinoma, external genital warts and actinic keratinosis23–25, where its mechanism of action is to orchestrate a pro-inflammatory response through TLR7. Here, TLR7 is linked to basal cell carcinoma.